DE19531254A1
(de)
*
|
1995-08-25 |
1997-02-27 |
Sueddeutsche Kalkstickstoff |
Verfahren zur Extraktion von Carotinfarbstoffen aus festen Naturstoffen
|
US20020082459A1
(en)
*
|
1997-05-28 |
2002-06-27 |
Bailey David T. |
High purity beta-carotene and process for obtaining same
|
DE19821009A1
(de)
*
|
1998-05-11 |
1999-11-18 |
Siegfried Peter |
Verfahren zur Extraktion von Carotinen aus Fetten und Ölen biologischen Ursprungs
|
CA2305091C
(en)
*
|
2000-04-12 |
2002-10-22 |
Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food |
Separation of carotenoids from fruits and vegetables
|
ES2168971B1
(es)
*
|
2000-07-19 |
2003-11-01 |
Antibioticos Sau |
Procedimiento de produccion de beta-caroteno.
|
US7192731B2
(en)
*
|
2001-05-24 |
2007-03-20 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), Volcani Center |
Methods for efficient extraction of carotenoids using an esterase
|
US20020177181A1
(en)
*
|
2001-05-24 |
2002-11-28 |
Agricultural Research Organization, The Volcani Center |
Increasing bioavailability of carotenoids
|
KR100465095B1
(ko)
*
|
2001-08-11 |
2005-01-05 |
엘지전자 주식회사 |
이중화 시스템에서 동적 스키마 변경을 위한 데이터 변환시스템 및 방법
|
US7329789B1
(en)
|
2001-10-25 |
2008-02-12 |
Phasex Corporation |
Method for extraction and concentration of carotenoids using supercritical fluids
|
US20040267033A1
(en)
*
|
2001-11-02 |
2004-12-30 |
Rao Jonnalagadda Raghunath |
Extraction of lutein from marigold meal
|
DE10252168B4
(de)
*
|
2002-11-09 |
2007-01-11 |
Degussa Ag |
Verwendung eines Verfahrens zur selektiven Abtrennung von flüchtigen Aromastoffen aus einphasigen, flüssigen Ausgangsmaterialien mit einem Fett- und/oder Öl-Gehalt ≦20 Gew.-%
|
US6909021B2
(en)
*
|
2003-03-27 |
2005-06-21 |
Alfalfa America, Inc. |
Method of extracting lutein from green plant materials
|
US6737552B1
(en)
*
|
2003-03-27 |
2004-05-18 |
Lance B. Crombie |
Method for extracting lutein from green plant materials
|
MY138963A
(en)
*
|
2003-08-27 |
2009-08-28 |
Malaysian Palm Oil Board |
One-stage and two-stage supercritical fluid extractions of carotenes concentrate, vitamin e concentrate and other minor components concentrates
|
US7572468B1
(en)
|
2004-12-28 |
2009-08-11 |
The United States Of America As Represented By The Secretary Of Agriculture |
Extraction of carotenoids from plant material
|
ATE550019T1
(de)
|
2005-05-17 |
2012-04-15 |
Merck Sharp & Dohme |
Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs
|
EP1818388B1
(de)
|
2006-02-10 |
2010-04-28 |
Carotech SDN. BHD |
Verfahren zur Gewinnung hochangereicherter Naturstoff-fraktionen aus Palmöl unter Verwendung von superkritischen und beinahe superkritischen Flüssigmedien
|
GB0603041D0
(en)
|
2006-02-15 |
2006-03-29 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
TW200813039A
(en)
|
2006-04-19 |
2008-03-16 |
Novartis Ag |
6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
|
CA2664113C
(en)
|
2006-09-22 |
2013-05-28 |
Merck & Co., Inc. |
Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer
|
US20110218176A1
(en)
|
2006-11-01 |
2011-09-08 |
Barbara Brooke Jennings-Spring |
Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
|
PL2109608T3
(pl)
|
2007-01-10 |
2011-08-31 |
Msd Italia Srl |
Indazole podstawione grupą amidową jako inhibitory polimerazy poli(ADP-rybozy)-(PARP)
|
WO2008106692A1
(en)
|
2007-03-01 |
2008-09-04 |
Novartis Vaccines And Diagnostics, Inc. |
Pim kinase inhibitors and methods of their use
|
KR20100017866A
(ko)
|
2007-05-21 |
2010-02-16 |
노파르티스 아게 |
Csf-1r 억제제, 조성물 및 사용 방법
|
CA2690191C
(en)
|
2007-06-27 |
2015-07-28 |
Merck Sharp & Dohme Corp. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
JP4969370B2
(ja)
*
|
2007-08-29 |
2012-07-04 |
Jx日鉱日石エネルギー株式会社 |
カロテノイドの製造方法
|
DE112010001347T5
(de)
|
2009-03-24 |
2012-07-05 |
Council Of Scientific And Industrial Research |
Verfahren zur Herstellung von kristallinen und nicht-hygroskopischen phenolreichen Farbfraktionen aus Pflanzen
|
WO2010114780A1
(en)
|
2009-04-01 |
2010-10-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of akt activity
|
US8765747B2
(en)
|
2009-06-12 |
2014-07-01 |
Dana-Farber Cancer Institute, Inc. |
Fused 2-aminothiazole compounds
|
BR112012008849A2
(pt)
|
2009-10-14 |
2015-09-22 |
Schering Corp |
composto, composição farmacêutica, e, uso de um composto
|
CN103080093A
(zh)
|
2010-03-16 |
2013-05-01 |
达纳-法伯癌症研究所公司 |
吲唑化合物及其应用
|
US20120321730A1
(en)
*
|
2010-04-29 |
2012-12-20 |
Synthite Industries Ltd. |
Capsicum annuum extract and process thereof
|
EP2584903B1
(de)
|
2010-06-24 |
2018-10-24 |
Merck Sharp & Dohme Corp. |
Neue heterozyklische verbindungen als erk-hemmer
|
CN103068980B
(zh)
|
2010-08-02 |
2017-04-05 |
瑟纳治疗公司 |
使用短干扰核酸(siNA)的RNA干扰介导的联蛋白(钙粘蛋白关联蛋白质),β1(CTNNB1)基因表达的抑制
|
SI2606134T1
(sl)
|
2010-08-17 |
2019-08-30 |
Sirna Therapeutics, Inc. |
RNA-INTERFERENČNO POSREDOVANO ZAVIRANJE IZRAŽANJA GENA VIRUSA HEPATITISA B (HBV) Z UPORABO KRATKE INTERFERENČNE NUKLEINSKE KISLINE (siNA)
|
US8883801B2
(en)
|
2010-08-23 |
2014-11-11 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
|
WO2012030685A2
(en)
|
2010-09-01 |
2012-03-08 |
Schering Corporation |
Indazole derivatives useful as erk inhibitors
|
EP2615916B1
(de)
|
2010-09-16 |
2017-01-04 |
Merck Sharp & Dohme Corp. |
Kondensierte pyrazolderivate als neue erk-hemmer
|
DK2632472T3
(en)
|
2010-10-29 |
2018-03-19 |
Sirna Therapeutics Inc |
RNA INTERFERENCE-MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERRING NUCLEIC ACIDS (SINA)
|
WO2012087772A1
(en)
|
2010-12-21 |
2012-06-28 |
Schering Corporation |
Indazole derivatives useful as erk inhibitors
|
IN2013MN02170A
(de)
|
2011-04-21 |
2015-06-12 |
Piramal Entpr Ltd |
|
EP2770987B1
(de)
|
2011-10-27 |
2018-04-04 |
Merck Sharp & Dohme Corp. |
Neue verbindungen als erk-hemmer
|
JP6106685B2
(ja)
|
2011-11-17 |
2017-04-05 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
C−jun−n−末端キナーゼ(jnk)の阻害剤
|
EP3919620A1
(de)
|
2012-05-02 |
2021-12-08 |
Sirna Therapeutics, Inc. |
Zusammensetzungen mit kurzer interferierender nukleinsäure (sina)
|
JP6280554B2
(ja)
|
2012-09-28 |
2018-02-14 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
Erk阻害剤である新規化合物
|
USRE48175E1
(en)
|
2012-10-19 |
2020-08-25 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
PL2925888T3
(pl)
|
2012-11-28 |
2018-03-30 |
Merck Sharp & Dohme Corp. |
Kompozycje i sposoby do stosowania w leczeniu nowotworów
|
WO2014100065A1
(en)
|
2012-12-20 |
2014-06-26 |
Merck Sharp & Dohme Corp. |
Substituted imidazopyridines as hdm2 inhibitors
|
WO2014120748A1
(en)
|
2013-01-30 |
2014-08-07 |
Merck Sharp & Dohme Corp. |
2,6,7,8 substituted purines as hdm2 inhibitors
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
EP3057955B1
(de)
|
2013-10-18 |
2018-04-11 |
Syros Pharmaceuticals, Inc. |
Zur behandlung von proliferativen erkrankungen geeignete heteroaromatische verbindungen
|
WO2015058140A1
(en)
|
2013-10-18 |
2015-04-23 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
|
DE102014000155A1
(de)
*
|
2014-01-02 |
2015-07-02 |
Clariant International Ltd. |
Verfahren zur Extraktion von Fucoxanthin
|
JO3589B1
(ar)
|
2014-08-06 |
2020-07-05 |
Novartis Ag |
مثبطات كيناز البروتين c وطرق استخداماتها
|
JP6861166B2
(ja)
|
2015-03-27 |
2021-04-21 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
サイクリン依存性キナーゼの阻害剤
|
EP3175897B1
(de)
|
2015-12-04 |
2018-04-04 |
Evonik Degussa GmbH |
Verbessertes verfahren zur extraktion von aromastoffen aus fetthaltigen und/oder wässrigen flüssigphasen
|
JOP20190055A1
(ar)
|
2016-09-26 |
2019-03-24 |
Merck Sharp & Dohme |
أجسام مضادة ضد cd27
|
US10975084B2
(en)
|
2016-10-12 |
2021-04-13 |
Merck Sharp & Dohme Corp. |
KDM5 inhibitors
|
CN110650976B
(zh)
|
2017-04-13 |
2024-04-19 |
赛罗帕私人有限公司 |
抗SIRPα抗体
|
US10947234B2
(en)
|
2017-11-08 |
2021-03-16 |
Merck Sharp & Dohme Corp. |
PRMT5 inhibitors
|
WO2019148412A1
(en)
|
2018-02-01 |
2019-08-08 |
Merck Sharp & Dohme Corp. |
Anti-pd-1/lag3 bispecific antibodies
|
WO2020033284A1
(en)
|
2018-08-07 |
2020-02-13 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
US11993602B2
(en)
|
2018-08-07 |
2024-05-28 |
Merck Sharp & Dohme Llc |
PRMT5 inhibitors
|
WO2024180169A1
(en)
|
2023-03-02 |
2024-09-06 |
Carcimun Biotech Gmbh |
Means and methods for diagnosing cancer and/or an acute inflammatory disease
|